Lack of cardiac benefit after intramyocardial or intravenous injection of mesenchymal stem cell-derived extracellular vesicles supports the need for optimized cardiac delivery

Authors

Mark Broadwin MD, Lehigh Valley Health NetworkFollow

Publication/Presentation Date

12-2023

Volume

7

Issue

33

Published In/Presented At

10.20517/2574-1209.2023.98

Disciplines

Medicine and Health Sciences

Department(s)

Department of Surgery, Fellows and Residents

Document Type

Article